Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: Potential modifying effect of BRCA1/BRCA2 mutation carrier status

Jane C. Figueiredo, Jennifer D. Brooks, David V. Conti, Jenny N. Poynter, Sharon N. Teraoka, Kathleen E. Malone, Leslie Bernstein, Won D. Lee, David J. Duggan, Ashley Siniard, Patrick Concannon, Marinela Capanu, Charles F. Lynch, Jørgen H. Olsen, Robert W. Haile, Jonine L. Bernstein

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Rare deleterious mutations in BRCA1 and BRCA2 are associated with an elevated risk of breast and ovarian cancer. Whether or not common variants in these genes are independently associated with risk of breast cancer remains unclear. In this study, we included 632 Caucasian women with asynchronous contralateral breast cancer (CBC, cases) and 1,221 women with unilateral breast cancer (UBC, controls) from the WECARE (Women's Environment, Cancer and Radiation Epidemiology) Study. BRCA1 and BRCA2 deleterious mutation status was measured using denaturing high-performance liquid chromatography followed by direct sequencing, yielding including 88 BRCA1 and 60 BRCA2 deleterious mutation carriers. We also genotyped samples on the Illumina Omni1-Quad platform. We assessed the association between CBC risk and common (minor allele frequency (MAF) > 0.05) single-nucleotide polymorphisms (SNPs) in BRCA1 (n SNPs = 22) and BRCA2 (n SNPs = 30) and haplotypes using conditional logistic regression accounting for BRCA1/BRCA2 mutation status. We found no significant associations between any single-SNPs or haplotypes of BRCA1 or BRCA2 and risk of CBC among all women. When we stratified by BRCA1 and BRCA2 mutation carrier status, we found suggestive evidence that risk estimates for selected SNPs in BRCA1 (rs8176318, rs1060915, and rs16940) and BRCA2 (rs11571686, rs206115, and rs206117) may differ in non-carriers and carriers of deleterious mutations in BRCA1 and BRCA2. One common haplotype on BRCA1 was inversely significantly associated with risk only among non-BRCA1 and BRCA2 carriers. The association between common variants in BRCA1 and BRCA2 and risk of CBC may differ depending on BRCA1 and BRCA2 mutation carrier status.

Original languageEnglish (US)
Pages (from-to)819-829
Number of pages11
JournalBreast Cancer Research and Treatment
Volume127
Issue number3
DOIs
StatePublished - Jun 2011

Keywords

  • BRCA1
  • BRCA2
  • Breast cancer
  • Contralateral
  • Haplotype
  • Polymorphism

Fingerprint Dive into the research topics of 'Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: Potential modifying effect of BRCA1/BRCA2 mutation carrier status'. Together they form a unique fingerprint.

Cite this